Literature DB >> 20156290

Epidermal growth factor receptor gene numerical aberrations are frequent events in actinic keratoses and invasive cutaneous squamous cell carcinomas.

Agustí Toll, Rocío Salgado, Mireia Yébenes, Gemma Martín-Ezquerra, Montserrat Gilaberte, Teresa Baró, Francesc Solé, Francisco Alameda, Blanca Espinet, Ramon Maria Pujol.   

Abstract

Epidermal growth factor receptor (EGFR) gene amplification and protein overexpression are common in several cancers. EGFR status has seldom been studied in cutaneous squamous carcinomas (SCCs), or their precursors, actinic keratoses (AKs). We evaluated the presence of EGFR genomic aberrations and EGFR protein overexpression in 25 AKs and 35 invasive SCCs by means of fluorescence in situ hybridization (FISH) and immunohistochemistry. EGFR numerical aberrations were detected in 52% of AKs and 77.1% of SCCs (P = 0.042). EGFR amplification was identified in 12% of AKs and 20% of SCCs. No differences regarding EGFR numerical aberrations were observed when AKs with high-grade dysplasia were compared with SCCs. A good correlation was observed between EGFR numerical aberrations and EGFR overexpression. Our results suggest that EGFR numerical aberrations occur in the early stages of epithelial carcinogenesis in skin, not playing a role in the progression from low-grade SCCs into more aggressive phenotypes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20156290     DOI: 10.1111/j.1600-0625.2009.01028.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  22 in total

1.  Nonsurgical innovations in the treatment of nonmelanoma skin cancer.

Authors:  Sadegh Amini; Martha H Viera; Whitney Valins; Brian Berman
Journal:  J Clin Aesthet Dermatol       Date:  2010-06

Review 2.  From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma.

Authors:  Vladimir Ratushny; Michael D Gober; Ryan Hick; Todd W Ridky; John T Seykora
Journal:  J Clin Invest       Date:  2012-02-01       Impact factor: 14.808

Review 3.  Targeting EGFR and sonic hedgehog pathways for locally advanced eyelid and periocular carcinomas.

Authors:  Vivian T Yin; Helen Merritt; Bita Esmaeli
Journal:  World J Clin Cases       Date:  2014-09-16       Impact factor: 1.337

Review 4.  [Current therapy of non-melanoma skin cancer].

Authors:  M Schlaak; W von Bartenwerffer; C Mauch
Journal:  Hautarzt       Date:  2011-06       Impact factor: 0.751

5.  Effective treatment of a platinum-resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibition.

Authors:  Carlo Capalbo; Francesca Belardinilli; Marco Filetti; Claudia Parisi; Marialaura Petroni; Valeria Colicchia; Alessandra Tessitore; Matteo Santoni; Anna Coppa; Giuseppe Giannini; Paolo Marchetti
Journal:  Mol Clin Oncol       Date:  2018-05-21

6.  Treatment of unresectable and metastatic cutaneous squamous cell carcinoma.

Authors:  Lee D Cranmer; Candace Engelhardt; Sherif S Morgan
Journal:  Oncologist       Date:  2010-12-08

7.  Targeted deletion of RasGRP1 impairs skin tumorigenesis.

Authors:  Amrish Sharma; Lauren L Fonseca; Cynthia Rajani; Jodi K Yanagida; Yuka Endo; J Mark Cline; James C Stone; Junfang Ji; Joe W Ramos; Patricia S Lorenzo
Journal:  Carcinogenesis       Date:  2014-01-24       Impact factor: 4.944

8.  Concomitant cetuximab and radiation therapy: A possible promising strategy for locally advanced inoperable non-melanoma skin carcinomas.

Authors:  Giuseppina Della Vittoria Scarpati; Francesco Perri; Salvatore Pisconti; Giuseppe Costa; Filippo Ricciardiello; Salvatore Del Prete; Alberto Napolitano; Marco Carraturo; Salvatore Mazzone; Raffaele Addeo
Journal:  Mol Clin Oncol       Date:  2016-01-27

9.  Locally advanced and unresectable cutaneous squamous cell carcinoma: outcomes of concurrent cetuximab and radiotherapy.

Authors:  Robert M Samstein; Alan L Ho; Nancy Y Lee; Christopher A Barker
Journal:  J Skin Cancer       Date:  2014-07-21

10.  New developments in the treatment of actinic keratosis: focus on ingenol mebutate gel.

Authors:  Brian Berman
Journal:  Clin Cosmet Investig Dermatol       Date:  2012-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.